BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35822939)

  • 21. The miR-25802/KLF4/NF-κB signaling axis regulates microglia-mediated neuroinflammation in Alzheimer's disease.
    Zhao K; Liu J; Sun T; Zeng L; Cai Z; Li Z; Liu R
    Brain Behav Immun; 2024 May; 118():31-48. PubMed ID: 38360375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
    Leng F; Edison P
    Nat Rev Neurol; 2021 Mar; 17(3):157-172. PubMed ID: 33318676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease.
    Czapski GA; Strosznajder JB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial pathogens induce neurodegeneration in Alzheimer's disease mice: protection by microglial regulation.
    Ganz T; Fainstein N; Elad A; Lachish M; Goldfarb S; Einstein O; Ben-Hur T
    J Neuroinflammation; 2022 Jan; 19(1):5. PubMed ID: 34991645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
    Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
    Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
    Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
    Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs.
    Medrano-Jiménez E; Meza-Sosa KF; Urbán-Aragón JA; Secundino I; Pedraza-Alva G; Pérez-Martínez L
    J Leukoc Biol; 2022 Jul; 112(1):47-77. PubMed ID: 35293018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial Function and Regulation during Development, Homeostasis and Alzheimer's Disease.
    Casali BT; Reed-Geaghan EG
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
    Ghosh S; Geahlen RL
    EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.
    Chen YH; Lin RR; Tao QQ
    Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca
    Di Benedetto G; Burgaletto C; Bellanca CM; Munafò A; Bernardini R; Cantarella G
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.
    Pimenova AA; Herbinet M; Gupta I; Machlovi SI; Bowles KR; Marcora E; Goate AM
    Neurobiol Dis; 2021 Jan; 148():105217. PubMed ID: 33301878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.
    Walker DG; Tang TM; Lue LF
    Exp Neurol; 2018 Nov; 309():91-106. PubMed ID: 30076830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.
    Lu J; Zhang J; Wang X; Yuan F; Xin B; Li J; Yang Q; Li X; Zhang J; Wang X; Fu J; Guo C
    Brain Res Bull; 2024 Jun; 212():110969. PubMed ID: 38705540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease.
    Dong Q; Fu H; Jiang H
    Biomed Pharmacother; 2024 Jul; 176():116880. PubMed ID: 38850652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer's Disease.
    Sorrentino S; Ascari R; Maderna E; Catania M; Ghetti B; Tagliavini F; Giaccone G; Di Fede G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.